Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-04-11 @ 4:30 AM
Study NCT ID:
NCT00122304
Status:
COMPLETED
Last Update Posted:
2007-02-21
First Post:
2005-07-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hemoglobinuria, Paroxysmal | View |
Keywords: